Neonatal Morbidities in Infants Born Late Preterm at 35-36 Weeks of Gestation: A Swedish Nationwide Population-based Study

Abstract

To assess risk for neonatal morbidities among infants born late preterm at 35-36 gestational weeks, early term (37-38weeks), and late-term (41weeks) infants, compared with full-term (39-40weeks) infants. This nationwide population-based cohort study included 1 650 450 non-malformed liveborn singleton infants born at 35-41weeks between 1998 and 2016 in Sweden. The relative risks for low Apgar score (0-3) at 5minutes; respiratory, metabolic, infectious, and neurologic morbidities; and severe neonatal morbidity (composite outcome) were adjusted for maternal, pregnancy, delivery, and infant characteristics. Compared with infants born at 39-40weeks, the adjusted relative risks and proportions of infants born at 35-36weeks were higher for metabolic morbidity 7.79 (95%, 7.61 to 7.97; 33.75% vs 3.11%), respiratory morbidity 5.54 (95% CI, 5.24 to 5.85; 5.49% vs 0.75%), severe neonatal morbidity 2.42 (95% CI, 2.27 to 2.59; 3.40% versus 1.03%), infectious morbidity 1.98 (95% CI, 1.83 to 2.14; 2.53% vs 0.95%), neurologic morbidity 1.74 (95% CI, 1.48 to 2.03; 0.54% vs 0.23%), and low Apgar score 2.07 (95% CI, 1.72 to 2.51; 0.42% vs 0.12%). The risks for respiratory, severe neonatal morbidity, infectious, neurologic morbidities, and low Apgar score were highest at 35weeks, gradually decreased until 39weeks, and increased during 39-41weeks. Infants born late preterm at 35-36weeks of gestation are at increased risk of neonatal morbidities, although the absolute risks for severe neonatal morbidities are low. Our findings reinforce the need of preventing late preterm delivery to decrease the burden of neonatal morbidity and help professionals and families with a better risk assessment.